Back
Trip.com Group Vs. Viking Therapeutics Industry Stock Comparison
Buy
72
TCOM
Trip.com Group
Last Price:
67.27
Seasonality Move:
-3.42%
Sell
45
VKTX
Viking Therapeutics
Last Price:
63.15
Seasonality Move:
38.04%
Buy
72
Trip.com Group (TCOM)
is a Buy
Is Trip.com Group a Buy, Sell or Hold?
- The current Trip.com Group [TCOM] share price is $67.24. The Score for TCOM is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- TCOM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $63.14. The Score for VKTX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TCOM Stock Price Chart
What is Trip.com Group's stock price today?
-
The Trip.com Group share price today is $67.24
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TCOM is experiencing selling pressure, which indicates risk of future bearish movement.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $63.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.
TCOM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.52 | Buy |
| Relative Strength Index (14 RSI): | 65.46 | Buy |
| Chaikin Money Flow: | -2238499 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (60.59 - 66.09) | Buy |
| Bollinger Bands (100): | (42.67 - 58.85) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.92 | Buy |
| Relative Strength Index (14 RSI): | 44.37 | Sell |
| Chaikin Money Flow: | -27799915 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (62.04 - 71.46) | Sell |
| Bollinger Bands (100): | (52.9 - 66.58) | Buy |
TCOM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.47 | Buy |
| 20-day SMA: | 63.08 | Buy |
| 50-day SMA: | 55.75 | Buy |
| 200-day SMA: | 48.63 | Buy |
| 8-day EMA: | 64.68 | Buy |
| 20-day EMA: | 62.57 | Buy |
| 50-day EMA: | 57.59 | Buy |
| 200-day EMA: | 49.05 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 72.43 | Sell |
| 20-day SMA: | 67.48 | Sell |
| 50-day SMA: | 64.43 | Sell |
| 200-day SMA: | 59.82 | Buy |
| 8-day EMA: | 69.69 | Sell |
| 20-day EMA: | 68.14 | Sell |
| 50-day EMA: | 65.07 | Sell |
| 200-day EMA: | 55.33 | Buy |
Trip.com Group Earnings Growth & TCOM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.16 per share, and an increase next year of $0.22 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.50 per share.
Trip.com Group Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||